View this in your browser
Banner image for CORIS Newsletter

CORIS Newsletter

In This Week's Issue

Funding opportunities from Brain Canada, JSTD/MRIS/OCE, the Ontario-China Research and Innovation Fund, and Institut Mittag-Leffler.


Funding Opportunities

Brain Canada Foundation: Multi-Investigator Research Initiative

Posted on Monday, December 12, 2016

Brain Canada is pleased to launch the “Improving Health Outcomes and Quality of Life” Multi-Investigator Research Initiative (MIRI). This initiative will support three-year MIRI research project(s) that address improving health outcomes, including quality of life, over a reasonably short period of time. This...

Read More →

Ontario-Jiangsu Industrial Research and Development Program (OJIRDP)

Posted on Wednesday, December 14, 2016

The Ontario-Jiangsu Industrial Research and Development Program (OJIRDP) will support joint industrial R&D projects focusing on the development of products or processes that lead to commercial success and socio-economic benefits for both jurisdictions.  This is a partnership of the Jiangsu Science and Technology...

Read More →

Ontario-China Research and Innovation Fund (OCRIF)

Posted on Wednesday, December 14, 2016

The Ontario-China Research and Innovation Fund (OCRIF) also has a Call for Proposals open to projects that support scientific and technological collaboration projects between China and Ontario, with a current emphasis on biomaterials. OCRIF is offered through a partnership with MRIS, China’s Ministry of Science...

Read More →

Institut Mittag-Leffler Research Program Grants

Posted on Friday, December 16, 2016

Institut Mittag-Leffler invites proposals for its research program grants. These support programs that enable scientists and postdoctoral students to collaborate in specialized areas of mathematics. Proposals that demonstrate scientific strength and timeliness, and the degree to which the program would benefit...

Read More →


Upcoming Deadlines


Contact Us

If you have any questions, please visit our Contact Us Page.